Vincenzo Cerundolo

Headley Way
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Journal: Nature communications

Published: April 24, 2024

Remodelling of the immune landscape by IFNγ counteracts IFNγ-dependent tumour escape in mouse tumour models.

Remodelling of the immune landscape by IFNγ counteracts IFNγ-dependent tumour escape in mouse tumour models.

Journal: Nature communications

Published: April 15, 2024

ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition.

ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition.

Journal: Cell reports

Published: July 03, 2023

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.

Journal: BJUI compass

Published: November 30, 2022

MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity.

MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity.

Journal: Cell reports

Published: October 25, 2022

Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.

Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.

Journal: Neuro-oncology

Published: April 25, 2022

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells.

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells.

Journal: JCI insight

Published: January 04, 2022

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.

Journal: eLife

Published: December 15, 2021

The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.

The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.

Journal: The Journal of biological chemistry

Published: November 20, 2021

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Journal: Nature communications

Published: November 02, 2021

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.

Journal: Journal for immunotherapy of cancer

Published: May 16, 2021

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Journal: Med (New York, N.Y.)

Published: March 05, 2021

Showing 1-12 of 113

Last Updated: 09/26/2026